Interaction Guide · Research summary

Can I take Magnesium with Cefuroxime?

Review Magnesium with Cefuroxime: absorption and effectiveness, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Check which magnesium product you use with cefuroxime. Magnesium-containing antacids need spacing from oral cefuroxime axetil, but the sources checked do not establish the same rule for every magnesium supplement. For a short-acting antacid, take the antibiotic at least one hour before or two hours after.

What this answer covers

Oral cefuroxime axetil with acid-neutralizing magnesium products, especially magnesium hydroxide antacids. Other magnesium salts, laxative preparations, dietary magnesium and parenteral routes need separate assessment.

Supplement or preparation
Magnesium
Medication ingredient
cefuroxime

Why does magnesium form matter?

A magnesium hydroxide antacid reduces stomach acidity. Other products use magnesium in different salts, amounts and formulations. The antibiotic label warns about gastric-acidity reduction rather than identifying the elemental word magnesium as a universal cause of treatment failure.

What interval applies to an antacid?

Use cefuroxime axetil at least one hour before, or two hours after, a short-acting magnesium antacid. A combined aluminum-magnesium product still fits that category. Ask for help with a repeated-dose antacid or laxative schedule instead of altering the antibiotic course.

What does laboratory research add?

A published experiment mixed cefuroxime sodium with several antacids in vitro. That does not measure the absorption of oral cefuroxime axetil in a person. It is retained as a limitation, not used to supply a clinical percentage or prove that all magnesium supplements behave the same way.

What about an injection or ordinary intake?

The acid-related mechanism applies to the oral prodrug and does not justify spacing an injected cefuroxime dose from dietary magnesium. The current evidence also does not establish a need to avoid magnesium-containing foods. Product identity is more useful than a blanket mineral restriction.

Evidence and practical considerations

Absorption & effectiveness

Check which magnesium product you use with cefuroxime. Magnesium-containing antacids need spacing from oral cefuroxime axetil, but the sources checked do not establish the same rule for every magnesium supplement. For a short-acting antacid, take the antibiotic at least one hour before or two hours after.

Exact scope
Oral cefuroxime axetil with acid-neutralizing magnesium products, especially magnesium hydroxide antacids. Other magnesium salts, laxative preparations, dietary magnesium and parenteral routes need separate assessment. with oral cefuroxime axetil, converted to cefuroxime; not injected cefuroxime sodium
Medication form and route
oral
Timing or duration
During co-use; study-specific durations are retained in the source summaries. No universal duration or dose-response inferred.

What remains uncertain

  • No exact magnesium-salt clinical trial isolated here. Cefuroxime-sodium laboratory results cannot be substituted for oral-axetil patient data.

Factors that may matter: exact supplement preparation and dose; oral versus nonoral medication route; other formula ingredients; gastric-acidity effect and concurrent treatment.

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: regulatory product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People receiving oral cefuroxime axetil tablets.

Reduced stomach acidity can lower oral bioavailability. Administer antibiotic at least one hour before or two hours after short-acting antacids. Label also warns about C. difficile-associated diarrhea.

How this applies: RxCUI 2194 active cefuroxime is reached after oral axetil conversion. Gastric-pH effect is restricted to oral axetil, not injected cefuroxime sodium. Exact package scope: Oral cefuroxime axetil with acid-neutralizing magnesium products, especially magnesium hydroxide antacids. Other magnesium salts, laxative preparations, dietary magnesium and parenteral routes need separate assessment.

Antacid class precaution does not quantify the effect of every mineral salt; tablets and suspension are not interchangeable milligram for milligram.

Source 2: government drug-identity reference

cancer.gov · Source check Sep 10, 2026

Population: Users of oral aluminum hydroxide and magnesium hydroxide suspension.

Identifies these hydroxides as acid-neutralizing antacid ingredients.

How this applies: Supports applying an antacid-class precaution to these acid-neutralizing preparations, not to all aluminum or magnesium exposures. Exact package scope: Oral cefuroxime axetil with acid-neutralizing magnesium products, especially magnesium hydroxide antacids. Other magnesium salts, laxative preparations, dietary magnesium and parenteral routes need separate assessment.

No clinical cefuroxime data or isolated ingredient effect size.

Source 3: in vitro interaction experiment

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Laboratory drug-availability systems, not patients.

Study addresses chemical availability in vitro. It does not report a human cefuroxime-axetil coadministration trial.

How this applies: Explicit exclusion boundary: not evidence that oral minerals reduce absorption of injected cefuroxime or a source for a clinical effect size. Exact package scope: Oral cefuroxime axetil with acid-neutralizing magnesium products, especially magnesium hydroxide antacids. Other magnesium salts, laxative preparations, dietary magnesium and parenteral routes need separate assessment.

Different medication preparation and nonclinical setting; abstract does not provide quantified results.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Narrows general magnesium avoidance to antacid-active products and explicitly excludes a nonclinical cefuroxime-sodium result as clinical proof.
Research summary published

Article revision: 98d7964b21738e27

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.